Samuel C. Wadsworth - 04 Jun 2024 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Reporting relationship: Director
Issuer ticker: DTIL
Reported as of: 04 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jun 2024, 16:36:14 UTC
Prior SEC filing: 07 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Dario Scimeca, Attorney-in-Fact for Samuel C. Wadsworth

Key filing fact

Samuel C. Wadsworth filed Form 4 for PRECISION BIOSCIENCES INC (DTIL) on 06 Jun 2024.

Key facts

This page summarizes Samuel C. Wadsworth's Form 4 filing for PRECISION BIOSCIENCES INC (DTIL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Jun 2024, 16:36.

Change

Previous filing in this sequence was filed on 07 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DTIL transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +9,826
Change %
Price: $0.000000
Shares after: 9,826
Date: 04 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,826
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares.

Footnote F2

The RSUs vest on the earlier to occur of (i) June 4, 2025 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.